Ms. Caudill brings more than 25 years of experience in the biotechnology and healthcare industries, including leadership roles in manufacturing, quality, and business development. She joined Halozyme as Chief Operations Officer in October 2023 and is responsible for the Manufacturing, Quality, and Development Engineering as well as Alliance and Project Management.
Prior to Halozyme, Ms. Caudill was the Chief Product Officer for Aeglea Biotherapeutics. She also previously held roles of increasing responsibility at Cambrex, Vaxgen, Genentech, Vetter Pharma, and Baxalta. She played a key role in establishing the manufacturing facility for Samsung Biologics in Korea while also negotiating strategic deals that drove revenue and future expansions of the campus. She started her career in the United States Air Force.
Ms. Caudill holds a B.S. in Biology and a B.A. in Psychology from The University of Texas and earned an M.B.A from Fordham University.